Europe’s medicines’ regulatory approved the Pfizer BioNtech vaccine to administer to children under 12 to 15 years. This paves the way for a broader rollout in the region after the US and Canada’s clearance for such vaccine rollout.

Leave a Reply

Your email address will not be published.